Dr. Shagroni is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Baylor Plz
Houston, TX 77030Phone+1 713-798-4951
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Rheumatology, 2017 - 2019
Baylor College of MedicineResidency, Internal Medicine, 2014 - 2017
University of Texas Medical Branch School of MedicineClass of 2014
Tulane UniversityM.Sc., Cellular and Molecular Biology
Certifications & Licensure
TX State Medical License 2016 - 2026
CA State Medical License 2017 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Alpha Omega Alpha
Publications & Presentations
PubMed
- 17 citationsSystematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumorsNoha Abdel-Wahab, Jean Tayar, Faisal Fa’ak, Gaurav Sharma, Maria A. Lopez-Olivo
Blood Advances. 2020-04-28 - 40 citationsStatin-associated autoimmune myopathy.Tasneam Shagroni, Chantel Park, Emilie Rouah, Onome Whiteru
Rheumatology. 2017-06-01 - 3 citationsA review of exercise pulmonary hypertension in systemic sclerosis.Faisal Shaikh, Zafia Anklesaria, Tasneam Shagroni, Rajeev Saggar, Luna Gargani
Journal of Scleroderma and Related Disorders. 2019-10-01
Journal Articles
- A review of exercise pulmonary hypertension in systemic sclerosisArticle Menu Access Options Full Article Content List Abstract Introduction Definitions Epidemiology Screening for SSc-PH Rationale for exercise provocation in SSc: a..., Journal of Scleroderma and Related Disorders, 6/14/2019
Abstracts/Posters
- Prevalence of Gastroesophageal Disease in Systemic Sclerosis and Its Impact on Lung Disease: Fact or FictionTasneam Shagroni, David Lin, Jeremy Wang, Isela Valera, Aly M Aly, Philip J. Clements, Daniel E. Furst, Rajan Saggar, Jeffrey Conklin and Suzanne Kafaja, American College of Rheumatology, Chicago, IL, 10/21/2018
Authored Content
- Chapter 36: Nonsteroidal Anti-Inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Nonopioid Analgesics & Drugs Used in GoutDecember 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
